New review of pharmacologic treatments for COVID-19

Medical News: The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918.

With so many drugs being tested against COVID-19, things can get a little confusing. In order to try and work out which drugs might work, researchers have reviewed what is currently known about how the virus infects cells and causes disease. They look at the evidence for whether chloroquine, remdisivir and other antivirals or existing drugs might be an effective treatment for COVID-19.

More than 300 active clinical treatment trials are underway. The recent review from Sanders et al published in JAMA summaries current evidence regarding major proposed treatments, re-purposed or experimental, for COVID-19 and provides a summary of current clinical experience and treatment guidance for this novel epidemic coronavirus.

Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

You may also like Essential marketers tips to avoid digital disruption in a COVID-19 world